Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lipocine (LPCN) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Lipocine (LPCN) over the last 13 years, with Q3 2025 value amounting to -$3.2 million.

  • Lipocine's Profit After Tax fell 4362.75% to -$3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.5 million, marking a year-over-year decrease of 3498.83%. This contributed to the annual value of $8352.0 for FY2024, which is 10005.11% up from last year.
  • According to the latest figures from Q3 2025, Lipocine's Profit After Tax is -$3.2 million, which was down 4362.75% from -$2.2 million recorded in Q2 2025.
  • In the past 5 years, Lipocine's Profit After Tax ranged from a high of $12.6 million in Q4 2021 and a low of -$6.8 million during Q2 2021
  • Moreover, its 5-year median value for Profit After Tax was -$2.6 million (2022), whereas its average is -$1.8 million.
  • As far as peak fluctuations go, Lipocine's Profit After Tax surged by 37983.26% in 2021, and later plummeted by 17606.95% in 2023.
  • Over the past 5 years, Lipocine's Profit After Tax (Quarter) stood at $12.6 million in 2021, then plummeted by 117.66% to -$2.2 million in 2022, then dropped by 2.35% to -$2.3 million in 2023, then surged by 178.09% to $1.8 million in 2024, then crashed by 278.82% to -$3.2 million in 2025.
  • Its Profit After Tax was -$3.2 million in Q3 2025, compared to -$2.2 million in Q2 2025 and -$1.9 million in Q1 2025.